-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, F462qAJv//UiJx/Sy3ZLZ4iV43n1LI9AMgRYe81+MOlBrbXr5EVJHbDEHgX8dvns SD1dua64e645okkRb/UMiw== 0001104659-08-072163.txt : 20081120 0001104659-08-072163.hdr.sgml : 20081120 20081120205226 ACCESSION NUMBER: 0001104659-08-072163 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20081118 FILED AS OF DATE: 20081120 DATE AS OF CHANGE: 20081120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BENDER LEWIS H CENTRAL INDEX KEY: 0001238705 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32715 FILM NUMBER: 081205205 MAIL ADDRESS: STREET 1: 765 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTERLEUKIN GENETICS INC CENTRAL INDEX KEY: 0001037649 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 943123681 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 135 BEAVER ST CITY: WATHAM STATE: MA ZIP: 02452 BUSINESS PHONE: 1-781-398-0700 MAIL ADDRESS: STREET 1: 135 BEAVER ST CITY: WATHAM STATE: MA ZIP: 02452 FORMER COMPANY: FORMER CONFORMED NAME: MEDICAL SCIENCE SYSTEMS INC DATE OF NAME CHANGE: 19971003 4 1 a4.xml 4 X0303 4 2008-11-18 0 0001037649 INTERLEUKIN GENETICS INC ILI 0001238705 BENDER LEWIS H C/O INTERLEUKIN GENETICS, INC. 135 BEAVER STREET WALTHAM MA 02452 0 1 0 0 Chief Executive Officer Common Stock 2008-11-18 4 P 0 100 0.41 A 10646 D Common Stock 2008-11-18 4 P 0 8200 0.42 A 18846 D Common Stock 2008-11-18 4 P 0 10000 0.498 A 28846 D Common Stock 2008-11-20 4 P 0 8235 0.32 A 37081 D Common Stock 2008-11-20 4 P 0 1765 0.33 A 38846 D Common Stock 2008-11-20 4 P 0 1700 0.35 A 40546 D Includes 2941 shares purchased on June 30, 2008 and 4605 shares purchased on September 30, 2008, pursuant to the Interleukin Genetics, Inc. Employee Stock Purchase Plan. /s/ Lewis H. Bender 2008-11-20 -----END PRIVACY-ENHANCED MESSAGE-----